5PSQ-052 Optimisation of human normal immunoglobulins in paediatric cancer: a multidisciplinary teamwork

BACKGROUND: Human normal immunoglobulins (HNIg) have multiple indications such as replacement therapy or as immunomodulatory therapy for several autoimmune disorders. The use of HNIg in cancer patients is controversial, especially in children. Since HNIg represents a high cost and is a limited resou...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur J Hosp Pharm
Hlavní autoři: Celma, M Sánchez, Busquets, F Bossacoma, Genestar, JL Vinent, Escoda, A Comes, Suárez, J Arrojo
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Group 2018
Témata:
Section 5: Patient safety and quality assurance
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535511/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.406
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky